This evidence is partly in line with previous findings in a subgroup (<60 years of age) of the community-based stroke-free cohort showing that baseline but also change in NfL levels were the two main determinants for explaining brain atrophy.21 It is also broadly consistent with recent evidence in mild SVD showing baseline NfL predicts risk of future lacunes.24 Here, NEFL is linked to Brain atrophy.